Nexplanon Removal: Subcutaneous vs. Topical Lidocaine

Last updated: July 8, 2020
Sponsor: Augusta University
Overall Status: Active - Recruiting

Phase

4

Condition

Contraception

Treatment

N/A

Clinical Study ID

NCT04467125
1288589-4
  • Ages > 18
  • Female
  • Accepts Healthy Volunteers

Study Summary

A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure and time to removal.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Females with Nexplanon implant in place, desiring removal No allergy to lidocaine orany component of EMLA cream Age greater than or equal to 18years English as primarylanguage Not pregnant

Exclusion

Exclusion Criteria:

  • pregnant non-emglish speaking age less than 18 yo Allergy to lidocaine or EMLA

Study Design

Total Participants: 40
Study Start date:
January 06, 2020
Estimated Completion Date:
May 31, 2023

Connect with a study center

  • Augusta University Ob/Gyn Resident Continuity Clinic

    Augusta, Georgia 30912
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.